Receive a FREE Mesothelioma Treatment
Information Packet

Mesothelioma

Phase II Randomized Study of Gemcitabine and Cisplatin With Malignant Mesothelioma

Phase II Randomized Study of Gemcitabine and Cisplatin With or Without Bevacizumab in Patients With Malignant Mesothelioma

Background:
Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Monoclonal antibodies such as bevacizumab can locate tumor cells and kill them without harming normal cells. It is not yet known if combination chemotherapy is more effective with or without bevacizumab in treating malignant mesothelioma. This is a Randomized phase II trial to compare the effectiveness of combination chemotherapy with or without bevacizumab in treating patients who have malignant mesothelioma.

Location/Contacts:
University of Chicago Cancer Research Center
Hedy L. Kindler, MD, Protocol Chair
Ph: 773-702-0360; 1-888-824-0200

California

Duarte
City of Hope Comprehensive Cancer Center
Marianna Koczywas, MD
Ph: 626-359-8111
1-800-826-4673
mkocywas@coh.org

Pasadena
City of Hope Medical Group
Mark V. McNamara, MD
Ph: 626-396-2900
mmcnmara@ccsmg.com

Sacramento
University of California Davis Cancer Center
David R. Gandara, MD
Ph: 916-734-3772
dgandara@cc.ucdmc.ucdavis.edu

Illinois

Chicago
Louis A. Weiss Memorial Hospital
Gary D. Steinberg, MD
Ph: 773-564-5272

University of Chicago Cancer Research Center
Hedy L. Kindler, MD
Ph: 773-702-0360
1-888-824-0200

Decatur
Decatur Memorial Hospital Cancer Center Institute
James L. Wade, MD
Ph: 217-876-6603

Harvey
Ingalls Memorial Hospital
Mark F. Kozloff, MD
Ph: 708-333-2300.

Sulochana D. Yalavarthi, MD
Ph: 708-915-6620

LaGrange
LaGrange Memorial Hospital
James E. Hannigan, MD
Ph: 708-579-3418

Renee H. Jacobs, MD
Ph: 708-579-3418

Maywood
Loyola University Medical Center
Joseph I. Clark, MD
Ph: 708-327-3236
jclark@lumc.edu

Kathy S. Albain, MD
Ph: 708-327-3102
kalbain@lumc.edu

Peoria
Oncology/Hematology Associates of Central Illinois, P.C.
James A. Knost, MD, FACP
Ph: 309-672-5681

John W. Kugler, MD
Ph: 309-671-3605

Indiana
Fort Wayne
Fort Wayne Medical Oncology and Hematology, Inc.
David Frank Sciortino, MD
Ph: 219-484-8830

Sreenivasa Rao Nattam, MD
Ph: 219-484-8830
800-852-2333
ledgar@fwmoh.com

South Bend
CCOP-Northern Indiana CR Consortium
David Allen Taber, MD
Ph: 800-284-7370

Rafat H. Ansari, MD, FACP
Ph: 219-234-5123

Michigan
Saint Joseph
Lakeland Medical Center - St. Joseph
Eric Lester, MD
Ph: 616-982-4963

New York
New York
Memorial Sloan-Kettering Cancer Center
Lee M. Krug, MD
Ph: 212-639-8420

Pennsylvania
Philadelphia
University of Pennsylvania Cancer Center
James Stevenson, MD
Ph: 215-662-8756

Texan
Houston
University of Texas - MD Anderson Cancer Center
Charles Lu, MD
Ph: 713-792-6363
1-800-392-1611